Beta-radiation to reduce restenosis. Too little, too soon?

With almost 1 million procedures undertaken worldwide each year, coronary angioplasty is flourishing. This elegant technique, however, continues to be plagued by a restenosis rate of 30% to 60%.1 Efforts to reduce restenosis have been herculean. Literally, scores of pharmaceutical agents have been tested in clinical trials.2 3 4 Despite initial promising results in experiments with animals, each clinical trial has been a disappointment. Coronary stents stand alone as the only intervention that has been proved to decrease restenosis. In the STRESS and BENESTENT trials, the implantation of a single Palmaz-Schatz coronary stent was associated with a 30% reduction in restenosis rates.5 6 The impact of stents on restenosis, however, is purely mechanical.7 8 Stent implantation expands the vessel lumen further than the use of balloon angioplasty alone. This larger lumen creates more space for the still ubiquitous intimal proliferation. Stents do not diminish the cellular response to injury. In fact, the proliferative response, as measured on the basis of late loss after the procedure, is actually increased by the use of stents. Stents decrease restenosis by simply increasing the capacity of the artery to tolerate intimal proliferation. Despite extensive clinical testing, no agent has been shown to inhibit the proliferative component of restenosis. Radiotherapy is the latest in a long line of potential antiproliferative agents to be enthusiastically tested as an adjunct to angioplasty. There is much to recommend the use of radiotherapy in the fight against restenosis. In more than 100 years of clinical experience, radiotherapy has proved to be highly effective in inhibiting cellular proliferation, in both malignant and benign disease. Examples of benign hyperplastic entities that have been effectively treated with radiotherapy include the exuberant fibroblastic activity of keloid scar formation, heterotopic ossification, desmoid/aggressive fibromatosis, Peyronie's disease, and pterygium.9 10 11 …

[1]  R. Virmani,et al.  Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. , 1996, Circulation.

[2]  H. Hammar,et al.  Treatment of keloids with excision and postoperative X-ray irradiation. , 1983, Dermatologica.

[3]  Philippe Nouet,et al.  Feasibility of Intracoronary β-Irradiation to Reduce Restenosis After Balloon Angioplasty A Clinical Pilot Study , 1997 .

[4]  J. Reitamo The desmoid tumor. IV. Choice of treatment, results, and complications. , 1983, Archives of surgery.

[5]  C M Gibson,et al.  Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.

[6]  D. Liermann,et al.  Endovascular irradiation--a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. , 1994, International journal of radiation oncology, biology, physics.

[7]  R. Datta,et al.  Postoperative beta radiation treatment of pterygium. , 1983, International journal of radiation oncology, biology, physics.

[8]  D. Baim,et al.  Novel approach to the analysis of restenosis after the use of three new coronary devices. , 1992, Journal of the American College of Cardiology.

[9]  W. Rutishauser,et al.  Intra-arterial 90Y brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon. , 1995, International journal of radiation oncology, biology, physics.

[10]  J. Wilcox,et al.  Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. , 1996, Circulation.

[11]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[12]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[13]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[14]  W. Kübler,et al.  Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. , 1995, Circulation.

[15]  P. Rubin,et al.  Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high risk group of patients. , 1984, International journal of radiation oncology, biology, physics.

[16]  R Waksman,et al.  Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. , 1995, Circulation.

[17]  H. Amols,et al.  Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. , 1994, Journal of the American College of Cardiology.

[18]  R. Califf,et al.  Clinical trials of restenosis after coronary angioplasty. , 1991, Circulation.